Found: 5
Select item for more details and to access through your institution.
Danazol as First-Line Therapy for Myelodysplastic Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reduced-dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Low‐dose rituximab plus high‐dose dexamethasone in newly diagnosed immune thrombocytopenia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Case series: CYP Inhibition and low dose ibrutinib for steroid‐refractory chronic graft‐versus‐host disease.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 573, doi. 10.1111/bjh.18712
- By:
- Publication type:
- Article
Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: A proof‐of‐concept case study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 898, doi. 10.1111/bcp.15590
- By:
- Publication type:
- Article